Riskpilot← Back to searchSign inGet full accessASAMEDIC AS
ASActiveOrg 912575586Rosenholmveien 25, 1414 TrollåsenResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20132 employees
Revenue 2024
NOK 1,2M
-65% vs 2023
EBITDA margin
-729.7%
-76% vs 2023
Equity ratio
95.8%
Financial strength
Net profit 2024
NOK -11,4M
-61% vs 2023
| Revenue | NOK 1,2M | -65% |
| EBITDA | NOK -9,1M | -76% |
| Net profit | NOK -11,4M | -61% |
| Total assets | NOK 33,5M | +32% |
| Equity | NOK 32,1M | +40% |
| Employees | 2 | — |
Legal name
ASAMEDIC AS
Org number
912575586
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
14. oktober 2013
Share capital
NOK 93 367
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Utvikle og markedsføre legemidler og alt som er i tilknytning til dette.
Address
Rosenholmveien 25, 1414 Trollåsen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 700 | 0 | 0 | 0 | 0 | 0 | 0 | 3 603 | 1 248 |
| Staff expenses | −0 | −0 | −1 288 | −1 503 | −1 476 | −1 771 | −1 536 | −1 615 | −1 420 | −1 867 | −4 185 |
| EBITDA | −21 | −86 | −1 025 | −2 427 | −3 030 | −3 355 | −3 774 | −3 810 | −3 203 | −5 162 | −9 110 |
| Depreciation & amort. | −0 | −0 | −6 | −39 | −56 | −8 | −0 | −293 | −1 274 | −1 913 | −1 880 |
| EBIT | −21 | −86 | −1 032 | −2 466 | −3 087 | −3 363 | −3 774 | −4 103 | −4 477 | −7 076 | −10 990 |
| Net financials | −0 | −0 | 13 | 47 | 54 | 71 | 71 | 5 | 25 | 100 | −345 |
| Profit before tax | −21 | −86 | −1 019 | −2 419 | −3 033 | −3 292 | −3 703 | −4 097 | −4 453 | −6 975 | −11 334 |
| Tax | −0 | −0 | −488 | −535 | 12 | −0 | −0 | −0 | −0 | 114 | 59 |
| Net profit | −21 | −86 | −531 | −1 884 | −3 045 | −3 292 | −3 703 | −4 097 | −4 453 | −7 090 | −11 394 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9 | 4 079 | 4 165 | 15 792 | 11 621 | 20 262 | 19 942 | 24 568 | 25 504 | 25 404 | 33 507 |
| Equity | 9 | 3 644 | 3 113 | 14 877 | 11 220 | 18 916 | 15 214 | 23 222 | 24 385 | 22 911 | 32 112 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 435 | 1 052 | 914 | 400 | 1 345 | 4 729 | 1 347 | 1 119 | 2 493 | 1 395 |
| Total debt | 0 | 435 | 1 052 | 914 | 400 | 1 345 | 4 729 | 1 347 | 1 119 | 2 493 | 1 395 |
EBITDA margin
-729.7%
This company
15.8%
Market median
-4718% vs market
20142024
Equity ratio
95.8%
This company
38.2%
Market median
+151% vs market
20142024
Return on equity
-35.5%
This company
18.4%
Market median
-293% vs market
20142024
Net profit margin
-912.7%
This company
8.1%
Market median
-11368% vs market
20142024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20142024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2013-10-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GI Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
DA | Board of Directors | 2025 | — | — |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Hamec As | Company | 22.0% | 22.0% | 2024 |
Wider Holding As | Company | 18.8% | 18.8% | 2024 |
| Individual | 12.6% | 12.6% | 2022 | |
| Individual | 10.7% | 10.7% | 2024 | |
| Individual | 7.0% | 7.0% | 2024 | |
SKI TANNLEGESENTER AS | Company | 1.9% | 1.9% | 2022 |
| Individual | 1.7% | 1.7% | 2024 | |
A. M. Ruud As | Company | 1.4% | 1.4% | 2024 |
Oseng As | Company | 1.4% | 1.4% | 2024 |
Bearhill As | Company | 1.4% | 1.4% | 2024 |
Wines Consulting As | Company | 1.4% | 1.4% | 2024 |
| Individual | 1.4% | 1.4% | 2024 | |
| Individual | 1.4% | 1.4% | 2024 | |
Trollåsen Legeservice As | Company | 1.3% | 1.3% | 2024 |
Bkraft Holding As | Company | 1.2% | 1.2% | 2024 |
Holmen Holding & Invest As | Company | 1.0% | 1.0% | 2024 |
Going Invest As | Company | 1.0% | 1.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ASAMEDIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geir Ivar Westen | Chief Executive Officer | 0 companies |
| Halvor Sørbye | Board of Directors | 0 companies |
| Dan Atar | Board of Directors | 0 companies |
| Peter Harry Norrgård | Board of Directors | 0 companies |
| Lise Renee Skarpås | Board of Directors | 0 companies |
| Leif Thoring | Chairman | 0 companies |